Company Overview

The Cannabist Company Holdings Inc. is a U.S.-based, vertically integrated cannabis company operating in the medical and adult-use cannabis industries. The company cultivates, manufactures, and retails cannabis products under a portfolio of brands, with revenue primarily generated through retail dispensary sales and wholesale distribution. It serves regulated state cannabis markets, focusing on patients and adult-use consumers in jurisdictions where cannabis is legal at the state level.

Formerly known as Columbia Care Inc., the company was founded in 2012 and initially focused on medical cannabis. It underwent significant expansion through acquisitions and organic growth, becoming one of the largest multi-state operators (MSOs) in the U.S. cannabis sector. In 2021, the company rebranded to The Cannabist Company to align its corporate identity with its flagship retail brand and broader consumer-facing strategy. Its strategic positioning emphasizes scale in limited-license markets, vertical integration, and branded retail experiences.

Business Operations

The company operates through three primary business activities: cultivation, manufacturing, and retail dispensaries, which together form a vertically integrated operating model. Revenue is predominantly derived from Retail Operations through The Cannabist and other dispensary brands, complemented by Wholesale Operations supplying branded cannabis products to third-party retailers. The company controls cultivation and production facilities that support both internal retail demand and external wholesale channels.

Operations span both domestic U.S. markets and select international medical cannabis activities, though the U.S. accounts for the substantial majority of revenue. The company owns and operates multiple subsidiaries that hold state-specific licenses, enabling compliance with local regulatory frameworks. Its asset base includes cultivation facilities, processing labs, branded product intellectual property, and retail storefronts, with no material reliance on joint ventures disclosed in public filings.

Strategic Position & Investments

The Cannabist Company’s strategic direction has focused on optimizing its existing footprint, improving operational efficiency, and strengthening its balance sheet following a period of rapid expansion. Growth initiatives have included rationalizing underperforming assets, prioritizing core markets, and enhancing retail productivity rather than aggressive new market entry. The company has publicly emphasized disciplined capital allocation in response to broader cannabis sector volatility.

Historically, the company expanded through acquisitions, most notably the acquisition of Green Leaf Medical and The Green Solution, which significantly increased its presence in key limited-license states. While large-scale acquisitions have slowed, the company continues to invest in product innovation, retail brand development, and emerging cannabis product categories where permitted by regulation. Its strategic focus remains aligned with long-term U.S. cannabis market normalization and potential federal reform.

Geographic Footprint

The company’s headquarters is located in the United States, and its operations span multiple U.S. states across the Northeast, Mid-Atlantic, Midwest, South, and West regions. Key markets have historically included states such as New York, New Jersey, Virginia, Pennsylvania, Florida, Ohio, and Arizona, reflecting a concentration in populous, limited-license jurisdictions.

Internationally, the company has maintained a limited footprint, primarily related to medical cannabis opportunities, with no material contribution to consolidated revenue based on publicly available disclosures. Its operational influence remains predominantly domestic, with strategic emphasis on scaling within existing U.S. markets rather than broad international expansion.

Leadership & Governance

The Cannabist Company is led by an executive team with experience in regulated industries, consumer packaged goods, and healthcare-adjacent sectors. Leadership has emphasized regulatory compliance, operational discipline, and long-term value creation in a complex and evolving legal environment. The company operates under a publicly listed governance framework, with oversight by a board of directors and adherence to U.S. and Canadian public company reporting standards.

Key executives include:

• David Hart – Chief Executive Officer
• David Windle – Chief Financial Officer
• Chris Beals – Chief Operating Officer
• Elizabeth Karr – Chief Marketing Officer
• Ritu Uppal – Chief Legal Officer

Leadership has articulated a strategic vision centered on stabilizing operations, strengthening core markets, and positioning the company to benefit from future regulatory and capital markets improvements in the cannabis industry.